Four serum neurofilament light chain tests show high accuracy in diagnosing ALS and predicting its progression, new research suggests.
Researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like Alzheimer's disease and amyotrophic lateral sclerosis ...
A study indicates ALS Functional Rating Scale-Revised self-assessments using a smartphone app were as reliable as those done ...
Cognixion's Axon-R headset is a device designed to read brain activity using EEG as a direct input for controls. Using brain ...
Working with mouse cells, the researchers developed a highly efficient conversion method that can produce more than 10 ...
Eight years after receiving a life-shattering diagnosis, a New Jersey mother credits an “amazing” new drug for stopping her ...
Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a ...
In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key ...
Patients with ALS often lose their ability to speak making it harder to communicate with their family. This AI-powered device ...
John Roehrig died March 8 after a battle with ALS. During his career, he was on the front lines of the U.S. response to West Nile virus.
As other gene editing programs fold or get sold, Arbor Biotechnologies has secured $73.9 million to advance its lead liver-targeting gene therapy into human trials. | As other gene editing programs ...